Objective: To test the hypothesis that felodipine, a renal vasodilator, can
prevent a release of hypoxanthine during rewarming after moderate hypother
mic cardiopulmonary bypass and that this is related to improved renal oxyge
n supply.
Design: A prospective, randomized, and controlled study.
Setting: Operating room in the cardiothoracic surgery department of a unive
rsity hospital.
Participants: Twenty-two patients submitted to elective first-time coronary
bypass surgery.
Interventions: A catheter was placed in the left renal vein for thermodilut
ion renal blood flow (RBF) measurement and blood sampling. In 11 patients,
felodipine was infused during the hypothermic period of cardiopulmonary byp
ass.
Measurements and Main Results: Renal uptake (renal arteriovenous concentrat
ion difference x RBF) of hypoxanthine was maintained during rewarming in fe
lodipine-treated patients but not in control patients (55 +/- 28 v -39 +/-
1 nmol/min, p < 0.05). Oxygen consumption was higher after felodipine infus
ion despite unchanged total RBF. A positive correlation between renal oxyge
n consumption and hypoxanthine uptake and release (r = 0.74, p < 0.01) was
observed.
Conclusions: Felodipine maintained renal uptake of hypoxanthine during rewa
rming after hypothermic cardiopulmonary bypass. This maintenance is the eff
ect of improved renal oxygen supply secondary to improved nutritive blood f
low at the expense of nonnutritive renal blood flow. Copyright (C) 1999 by
W.B. Saunders Company.